Paclitaxel extravasation treated with systemic corticosteroids.

Humans Paclitaxel / adverse effects Antineoplastic Agents, Phytogenic / adverse effects Quality of Life Extravasation of Diagnostic and Therapeutic Materials Skin

Journal

Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847

Informations de publication

Date de publication:
Dec 2022
Historique:
accepted: 27 07 2022
pubmed: 30 7 2022
medline: 30 11 2022
entrez: 29 7 2022
Statut: ppublish

Résumé

Chemotherapy extravasation is a rare but severe cutaneous complication associated with administration of intravenous chemotherapy. Extravasation causes serious disability and diminishes the quality of life in patients with cancer undergoing antineoplastic therapy. Treatment of chemotherapy extravasation is not standardized. We report a patient with paclitaxel extravasation who was successfully treated with corticosteroids.

Identifiants

DOI: 10.1111/ced.15348 PMID: 35906023
pubmed: 35906023
doi: 10.1111/ced.15348
doi:

Substances chimiques

Paclitaxel P88XT4IS4D
Antineoplastic Agents, Phytogenic 0

Types de publication

Case Reports Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

2295-2296

Informations de copyright

© 2022 British Association of Dermatologists.

Auteurs

Mouna Cheour (M)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Colandane Belajouza (C)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Linda Manaa (L)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
ORCID: 0000-0002-7645-7774

Maha Lahouel (M)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
ORCID: 0000-0003-0945-5442

Nedia Ghariani Fetoui (NG)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Sana Mokni (S)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Najet Ghariani (N)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Amina Aounallah (A)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Mohamed Denguezli (M)

Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Paclitaxel extravasation treated with systemic...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Terpènes › Diterpènes › Taxoïdes › Paclitaxel › Paclitaxel extravasation treated with systemic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Antinéoplasiques d'origine végétale › Paclitaxel extravasation treated with systemic...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Paclitaxel extravasation treated with systemic...
questionsmedicales.fr › Plaies et blessures › Extravasation de produits diagnostiques ou thérapeutiques › Paclitaxel extravasation treated with systemic...
questionsmedicales.fr › Système tégumentaire › Peau › Paclitaxel extravasation treated with systemic...